JAMA:孕产妇SARS-CoV-2感染与新生儿结局的关联

2021-04-30 MedSci原创 MedSci原创

自COVID-19大流行开始以来,如何保护弱势人群免受SARS-CoV-2侵害始终是一个大问题。 过去,新生婴儿在大流行中的死亡率增加,并且感染是5岁以下儿童死亡的最常见原

    自COVID-19大流行开始以来,如何保护弱势人群免受SARS-CoV-2侵害始终是一个大问题。 过去,新生婴儿在大流行中的死亡率增加,并且感染是5岁以下儿童死亡的最常见原因。 

    在受COVID-19早期影响的国家中,医疗指导方针有着不可推卸的责任。他们建议在分娩后就将母婴分离,以防母亲分娩时SARS-CoV-2呈阳性反应。而在其他指导方针中, 则不建议母婴分离,同时也鼓励母乳喂养。 尽管对COVID-19阳性母亲的新生儿的管理建议有所不同,但它们都受到不确定性的阻碍,并且无论出生后对母婴互动的干扰过大或过少,都有可能带来严重的不良影响。系统评价 已经开始阐明孕产妇和妊娠结局,但是关于孕产妇COVID-19妊娠后的新生儿结局的知识仍然基于病例系列和中心经验。由于潜在的选择偏见,分母缺乏,缺乏现代的可比性以及局限性,且通常报道的症状不明确且预后指标不明确,没有足够的数据能够得出有关孕妇COVID-19阳性妊娠后新生儿并发症的可靠结论。全面的评估将有助于为临床实践建立更可靠的证据基础。为了检验孕妇的SARS-CoV-2阳性可能与不良的新生儿结局有关这一假说,瑞典进行了一项全国性的前瞻性队列研究。


    本文是基于瑞典妊娠登记册,新生儿质量登记册和传染病登记册之间的联系,在全国范围内进行的前瞻性队列研究。 到2021年3月8日,瑞典将调查2020年3月11日至2021年1月31日之间瑞典全部活产的92%的新生儿结局。 将SARS-CoV-2检测呈阳性的妇女所生下的婴儿,按倾向得分直接与多达4名对照婴儿匹配。


    主要结局和方法包括:院内死亡率; 新生儿复苏; 入院接受新生儿护理; 呼吸系统,循环系统,神经系统,感染性,胃肠道,代谢和血液系统疾病及其治疗; 住院时间; 哺乳;婴儿对SARS-CoV-2的阳性反应。


    在88159例婴儿(女孩占49%)中,有2323例(占1.6%)是由SARS-CoV-2检测呈阳性的母亲分娩的。 SARS-CoV-2阳性母亲的婴儿的平均胎龄为39.2周(SD,2.2),而对照婴儿为39.6周(SD,1.8),早产儿(胎龄<37周)在SARS-CoV-2阳性母亲的婴儿中的比例为205/2323(8.8%),在对照婴儿中为4719/85836(5.5%)。在匹配孕产妇特征后,孕产妇SARS-CoV-2检验阳性率与入院新生儿护理显着相关(11.7%vs 8.4%;优势比[OR],1.47; 95%CI,1.26-1.70),并与新生儿发病率相关,例如呼吸窘迫综合征(1.2%vs 0.5%; OR,2.40; 95%CI,1.50-3.84),任何新生儿呼吸系统疾病(2.8%vs 2.0%; OR,1.42; 95%CI,1.07-1.90)和高胆红素血症 (3.6%vs 2.5%; OR,1.47; 95%CI,1.13-1.90)。死亡率(0.30%vs 0.12%; OR,2.55; 95%CI,0.99-6.57),出院时母乳喂养率(94.4%vs 95.1%; OR,0.84; 95%CI,0.67-1.05),新生儿护理时间(两组中位数为6天;差异为0天; 95%CI为-2至7天)在两组之间无显着差异。 21例SARS-CoV-2阳性母亲的婴儿在新生儿期检测出SARS-CoV-2阳性。 12例没有新生儿发病,9例诊断与SARS-CoV-2的关系不清楚,也没有人患有先天性肺炎。


    在瑞典的全国婴儿队列中,孕妇的SARS-CoV-2感染与某些新生儿发病率的小幅上升显着相关。 鉴于许多结果中的事件较少,并且统计比较也很多,因此,应将调查结果解释为探索性的。

 

原文链接:https://jamanetwork.com/journals/jama/fullarticle/2779586

Norman M, Navér L, Söderling J, et al. Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes. JAMA. Published online April 29, 2021. doi:10.1001/jama.2021.5775

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1938006, encodeId=d5581938006d0, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 30 20:13:16 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321272, encodeId=0c7f13212e2fe, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun May 02 00:13:16 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961833, encodeId=be4596183359, content=<a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 16:55:48 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036594, encodeId=ea4a1036594eb, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Fri Apr 30 12:13:16 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961758, encodeId=86c0961e5833, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/622cb8c78c214d56ad51af367cc34ca7/4cbd4bf7ed8d4c2f955fa0bf141ad145.jpg, createdBy=a6da5490007, createdName=随风w, createdTime=Fri Apr 30 10:22:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961753, encodeId=5de9961e5320, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:37:19 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961751, encodeId=c891961e5124, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:26:45 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2022-03-30 hukaixun
  2. [GetPortalCommentsPageByObjectIdResponse(id=1938006, encodeId=d5581938006d0, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 30 20:13:16 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321272, encodeId=0c7f13212e2fe, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun May 02 00:13:16 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961833, encodeId=be4596183359, content=<a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 16:55:48 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036594, encodeId=ea4a1036594eb, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Fri Apr 30 12:13:16 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961758, encodeId=86c0961e5833, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/622cb8c78c214d56ad51af367cc34ca7/4cbd4bf7ed8d4c2f955fa0bf141ad145.jpg, createdBy=a6da5490007, createdName=随风w, createdTime=Fri Apr 30 10:22:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961753, encodeId=5de9961e5320, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:37:19 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961751, encodeId=c891961e5124, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:26:45 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2021-05-02 小刀医生
  3. [GetPortalCommentsPageByObjectIdResponse(id=1938006, encodeId=d5581938006d0, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 30 20:13:16 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321272, encodeId=0c7f13212e2fe, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun May 02 00:13:16 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961833, encodeId=be4596183359, content=<a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 16:55:48 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036594, encodeId=ea4a1036594eb, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Fri Apr 30 12:13:16 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961758, encodeId=86c0961e5833, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/622cb8c78c214d56ad51af367cc34ca7/4cbd4bf7ed8d4c2f955fa0bf141ad145.jpg, createdBy=a6da5490007, createdName=随风w, createdTime=Fri Apr 30 10:22:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961753, encodeId=5de9961e5320, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:37:19 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961751, encodeId=c891961e5124, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:26:45 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2021-04-30 MedSciZeng
  4. [GetPortalCommentsPageByObjectIdResponse(id=1938006, encodeId=d5581938006d0, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 30 20:13:16 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321272, encodeId=0c7f13212e2fe, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun May 02 00:13:16 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961833, encodeId=be4596183359, content=<a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 16:55:48 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036594, encodeId=ea4a1036594eb, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Fri Apr 30 12:13:16 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961758, encodeId=86c0961e5833, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/622cb8c78c214d56ad51af367cc34ca7/4cbd4bf7ed8d4c2f955fa0bf141ad145.jpg, createdBy=a6da5490007, createdName=随风w, createdTime=Fri Apr 30 10:22:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961753, encodeId=5de9961e5320, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:37:19 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961751, encodeId=c891961e5124, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:26:45 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2021-04-30 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1938006, encodeId=d5581938006d0, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 30 20:13:16 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321272, encodeId=0c7f13212e2fe, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun May 02 00:13:16 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961833, encodeId=be4596183359, content=<a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 16:55:48 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036594, encodeId=ea4a1036594eb, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Fri Apr 30 12:13:16 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961758, encodeId=86c0961e5833, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/622cb8c78c214d56ad51af367cc34ca7/4cbd4bf7ed8d4c2f955fa0bf141ad145.jpg, createdBy=a6da5490007, createdName=随风w, createdTime=Fri Apr 30 10:22:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961753, encodeId=5de9961e5320, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:37:19 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961751, encodeId=c891961e5124, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:26:45 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2021-04-30 随风w

    有用

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1938006, encodeId=d5581938006d0, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 30 20:13:16 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321272, encodeId=0c7f13212e2fe, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun May 02 00:13:16 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961833, encodeId=be4596183359, content=<a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 16:55:48 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036594, encodeId=ea4a1036594eb, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Fri Apr 30 12:13:16 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961758, encodeId=86c0961e5833, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/622cb8c78c214d56ad51af367cc34ca7/4cbd4bf7ed8d4c2f955fa0bf141ad145.jpg, createdBy=a6da5490007, createdName=随风w, createdTime=Fri Apr 30 10:22:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961753, encodeId=5de9961e5320, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:37:19 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961751, encodeId=c891961e5124, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:26:45 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2021-04-30 ms2000002016659512

    特别好

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1938006, encodeId=d5581938006d0, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 30 20:13:16 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321272, encodeId=0c7f13212e2fe, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sun May 02 00:13:16 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961833, encodeId=be4596183359, content=<a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 16:55:48 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036594, encodeId=ea4a1036594eb, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Fri Apr 30 12:13:16 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961758, encodeId=86c0961e5833, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/622cb8c78c214d56ad51af367cc34ca7/4cbd4bf7ed8d4c2f955fa0bf141ad145.jpg, createdBy=a6da5490007, createdName=随风w, createdTime=Fri Apr 30 10:22:07 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961753, encodeId=5de9961e5320, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:37:19 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961751, encodeId=c891961e5124, content=特别好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e635479749, createdName=ms2000002016659512, createdTime=Fri Apr 30 09:26:45 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2021-04-30 ms2000002016659512

    特别好

    0